… survival compared to patients with ER+/PR+ (estrogen receptor positive and progesterone
… Controversy exists regarding the efficacy of hormone blocking therapy for patients with ER+/…

… Patients with an estrogen recep- … to have a better mean survival (41 months) than patients
cytoreduction was the same throughout the years of the with estrogen receptor levels greater …

… , but significantly better overall survival of anti-estrogen receptor therapy is documented (14). …
showed significantly favourable influence on survival in female patients, while PgR was an …

… This assertion was supported by the patients who were initially PR+ and who converted …
survival than those who remained PR+ (P = 0.02) [9]. In this series, there were only six patients …

… the ability of the tissues to bind either estrogen or progesterone; all that is detected by either
… to ER or PR) is the presence of estrogen or progesterone receptors and no indication of their …

… also can be associated with poorer survival [8]. This decrease in survival could perhaps be a
result of … the effects of HR expression discordance throughout therapy on patient survival [6]. …

… survival. Overall survival has not been examined yet because this study is not large enough
and because the study has a relatively short follow-up (there are not many dead events). …

… if tumor estrogen receptor (ER) or progesterone receptor (PR) status were significant
prognostic variables of survival and progression-free survival among patients with International …

… patients aged under 50 receiving toremifene as an adjuvant therapy, this report was aimed
at tamoxifen therapy in very young breast cancer patients, … estrogen or progesterone receptor …

… of estrogen receptors in breast cancers is now accepted as a predictor of extended disease-free
survival, but the relative value of progesterone … survival than patients who had estrogen …